Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease.

Bell CC, Hendriks DF, Moro SM, Ellis E, Walsh J, Renblom A, Fredriksson Puigvert L, Dankers AC, Jacobs F, Snoeys J, Sison-Young RL, Jenkins RE, Nordling Å, Mkrtchian S, Park BK, Kitteringham NR, Goldring CE, Lauschke VM, Ingelman-Sundberg M. · 2016

Read Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease. by Bell CC, Hendriks DF, Moro SM, Ellis E, Walsh J, Renblom A, Fredriksson Puigvert L, Dankers AC, Jacobs F, Snoeys J, Sison-Young RL, Jenkins RE, Nordling Å, Mkrtchian S, Park BK, Kitteringham NR, Goldring CE, Lauschke VM, Ingelman-Sundberg M. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4855186.txt.

Introduction

Caroline C. Bell and a large team built liver cell balls, called spheroids, in 2016 as a better lab model of the human liver. Flat liver cell cultures lose their character fast, which limits drug safety tests. The team grew primary human liver cells as tiny 3D balls in defined, serum-free fluid and checked their protein makeup in depth.

The balls matched real liver closely and kept each donor's traits. They stayed stable and working for at least five weeks. Under long dosing, they flagged liver harm from test drugs at doses seen in patients, including a drug whose harm hid in short tests. Drug makers gain a sturdier screen for liver risk.

Catalog record

CREATORBell CC, Hendriks DF, Moro SM, Ellis E, Walsh J, Renblom A, Fredriksson Puigvert L, Dankers AC, Jacobs F, Snoeys J, Sison-Young RL, Jenkins RE, Nordling Å, Mkrtchian S, Park BK, Kitteringham NR, Goldring CE, Lauschke VM, Ingelman-Sundberg M.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE52 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4855186

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease By Catherine C Bell, Delilah F G Hendriks, Sabrina M L Moro, Ewa Ellis, Joanne Walsh, Anna Renblom, Lisa Fredriksson Puigvert, Anita C A Dankers, Frank Jacobs, Jan Snoeys, Rowena L Sison-Young, Rosalind E Jenkins Published in: Scientific Reports DOI: 10.1038/srep25187 ABSTRACT Abstract Liver biology and function, drug-induced liver injury (DILI) and liver diseases are difficult to study using current in vitro models such as primary human hepatocyte (PHH) monolayer cultures, as their rapid de-differentiation restricts their usefulness substantially. Thus, we have developed and extensively characterized an easily scalable 3D PHH spheroid system in chemically-defined, serum-free conditions. Using whole proteome analyses, we found that PHH spheroids cultured this way were similar to the liver in vivo and even retained their inter-individual variability. Furthermore, PHH spheroids remained phenotypically stable and retained morphology, viability, and hepatocyte-specific functions for culture periods of at least 5 weeks. We show that under chronic exposure, the sensitivity of the hepatocytes drastically increased and toxicity of a set of hepatotoxins was detected at clinically relevant concentrations. An interesting example was the chronic toxicity of fialuridine for which hepatotoxicity was mimicked after repeated-dosing in the PHH spheroid model, not possible to detect using previous in vitro systems. Additionally, we provide proof-of-principle that PHH spheroids can reflect liver pathologies such as cholestasis, steatosis and viral hepatitis. Combined, our results demonstrate that the PHH spheroid system presented here constitutes a versatile and promising in vitro system to study liver function, liver diseases, drug targets and long-term DILI. The liver is a vital organ for synthesis, metabolism and detoxification, but liver diseases and drug-induced liver injury (DILI) can severely impair liver functionality. To study liver biology and function, drug-induced hepatotoxicity and liver diseases, primary human hepatocytes (PHH) are currently considered as the gold standard in vitro model system1. However, when maintained in conventional 2D monolayer cultures, PHH de-differentiate and rapidly lose hepatocyte-specific functions2,3,4. Thus, the utility of conventional 2D PHH cultures for the long-term study of liver biology and assays that require liver-specific functionalities is largely impaired. There is therefore a need for more faithful in vitro models which more accurately reflect in vivo liver biology. To this end, new systems are needed in which stable liver functionality can be maintained for several weeks to enable long-term studies of liver function under normal and diseased conditions. Normal cell physiology and function strongly depend on cell-cell and cell-extracellular matrix (ECM) interactions in the 3D tissue environment5. In an attempt to mimic the hepatic microenvironment, various more complex culture systems have been developed including sandwich cultures, and 3D models such as scaffold-based systems and bioreactors6,7,8,9,10,11,12. However, major drawbacks of these culture systems include lack of scalability, binding of drugs to scaffold, difficulties in handling and batch-to-batch differences of ECM substrates, which affect reproducibility11. To circumvent these problems, hepatocytes can be cultured as 3D microtissues termed spheroids13,14,15,16. In spheroid culture, it has previously been shown that PHH can be maintained for longer periods of time with stable viability and production of essential molecules such as albumin and urea14,15,16. Furthermore, cellular polarity and formation of functional bile ducts has been described14. However, a full phenotypic characterization as well as a comprehensive assessment of the suitability of the PHH spheroid model in the context of studying e.g. liver diseases and chronic DILI is lacking. Here, we have developed and extensively characterized an easily scalable 3D PHH spheroid system in serum-free, chemically-defined conditions, suitable for long-term functional and toxicological studies. Importantly, PHH spheroids closely resembled the in vivo liver tissue from where they originated more than spheroid cultures isolated from other donors, as determined by whole proteome analyses. Thus, inter-individual variability is maintained on a global scale. The PHH spheroids presented here remained phenotypically stable and retained morphology, viability, and hepatocyte-specific functions for culture periods of at least 5 weeks. The culture conditions allowed co-culture of PHH spheroids with non-parenchymal cells (NPCs) such as biliary cells, stellate cells and Kupffer cells and supported their long-term viability. Furthermore, liver diseases such as steatosis, cholestasis and viral hepatitis could be induced and the spheroids could predict chronic drug toxicity in particular of fialuridine, a drug which previously caused several deaths in a clinical trial while having previously passed all pre-clinical safety assessments17. Combined, these results indicate that the PHH spheroid system developed here constitutes a promising and versatile in vitro model to study various aspects of liver function, liver disease and DILI. RESULTS Characterization of PHH spheroid morphology and function In order to constitute a relevant hepatic in vitro system, cultured hepatocytes need to accurately reflect phenotypes and functionality seen in vivo. Therefore, PHH spheroid phenotypes and their molecular signatures were assessed and compared to freshly isolated cells from the same donor. Once spheroids had formed and showed well-defined perimeters (Fig. 1A), proteomic analyses were performed using an unbiased global proteomic approach. PHH spheroids after aggregation (7 d 3D) and cells from the same donors that were cultured in 2D as conventional monolayers (24 h 2D and 7 d 2D) were compared with the corresponding livers from which they originated (n = 5). Strikingly, it was found that proteomic signatures underwent wide-scale and rapid changes in 2D monolayer culture (Fig. 1B). Already after 24 h, expression of 457 proteins (13.9% of the entire detected proteome, p < 0.05, F-test) was significantly affected. After 7 d in 2D monolayer culture, 358 proteins were differentially expressed, of which 282 (78.8%) were already differentially expressed after 24 h. [Figure: 3D spheroids from PHH closely resemble the in vivo liver at the proteome level.(A) Time series showing progressing spheroid aggregation over time. Spheroid formation was judged complete after 7 d when a well-defined perimeter could be observed. Scale bar = 100 μm. (B) Heatmap visualizing whole proteome analysis of primary human liver samples (n = 5) after 24 h and 7 d in 2D monolayer culture and spheroids after aggregation (7 d 3D). Only differentially expressed proteins (n = 574 proteins, p < 0.05, F-test) are shown. Note that in vivo liver samples (black) and spheroids (green) cluster closely together while the proteomes of samples cultured in 2D (24 h = blue; 7 d = red) are distinctly different. (C) Principle component analysis separates proteomes from liver and PHH spheroids from 2D monolayer-cultured samples. (D) In vivo phenotypes are preserved in 3D culture, with each of the 3D samples clustering with the respective liver piece from the same donor. (E) Venn diagram showing differentially regulated pathways after 24 h 2D, 7 d 2D and 7 d 3D as suggested by GSEA. Numbers in circles indicate numbers of differentially expressed genes compared to liver with p < 0.05. Extensive misregulation of a variety of important metabolic and signaling pathways is observed in 2D such as glycolysis, gluconeogenesis, Hippo-signaling and apoptosis. In contrast, the proteomes of 3D PHH spheroid cultures closely resemble in vivo livers. Indicated p-values are after Benjamini-Hochberg multiple testing correction. (F) Heatmap showing all proteins involved in absorption, distribution, metabolism and excretion (ADME) of compounds that we detected in our dataset. Note that livers and PHH spheroids cultures cluster together, similar to when whole

Read the complete text